Trial Profile
A model of skin inflammation in humans leads to a rapid and reproducible increase in the interferon response signature: a potential translational model for drug development
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Imiquimod (Primary)
- Indications Actinic keratosis; Basal cell cancer; Genital warts
- Focus Therapeutic Use
- 27 Feb 2016 New trial record